×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ £¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

Ë«·Ö×ÓÓ«¹â»¥²¹ÊÖÒÕЧÀÍ

2017-06-27
|
»á¼ûÁ¿£º

Ò»¡¢ÊÖÒÕ¼ò½é

BiFCÊÇÓÉHuµÈÔÚ2002Äê×îÏȱ¨µÀµÄÒ»ÖÖÖ±¹Û¡¢¿ìËÙµØÅжÏÄ¿µÄÂѰ×ÔÚ»îϸ°ûÖеĶ¨Î»ºÍÏ໥×÷ÓõÄÐÂÊÖÒÕ ¡£

×ðÁú¿­Ê±½¨ÉèºÍÍêÉÆÁËPROTACÉúÎïɸѡÓë²âÊÔÆ½Ì¨ £¬×ðÁú¿­Ê±ÉúÎﲿ¾ßÓгÉÊìµÄPROTAC¹¦Ð§¼ì²â¼°ÑéÖ¤ÊÖÒÕ £¬Ê¹ÓÃÈÚºÏÂѰױí´ï¼°Ë«Ó«¹â·Ö×Ó»¥²¹£¨BiFC)µÈÊÖÒÕ £¬½¨ÉèÁ˸ßͨÁ¿PROTAC ɸѡƽ̨ £¬ÓÃÒÔɸѡ°ÐÏò½µ½âÖ²¡ÂѰ׵ÄPROTACС·Ö×Ó ¡£

Óб¨µÀÔÚGFPµÄÁ½¸ö¦ÂƬ²ãÖ®¼äµÄ»·½á¹¹£¨loop£©ÉÏÓÐÐí¶àÌØÒìλµã¿ÉÒÔ²åÈëÍâÔ´ÂѰ׶ø²»Ó°ÏìGFPµÄÓ«¹â»îÐÔ £¬BiFCÊÖÒÕÕýÊÇʹÓøÃÓ«¹âÂѰ׼Ò×åµÄÕâÒ»ÌØÕ÷ £¬½«Ó«¹âÂѰ×Ö§½â³ÉÁ½¸ö²»¾ßÓÐÓ«¹â»îÐԵķÖ×ÓÆ¬¶Ï £¬ÔÙ»®·ÖÓëÄ¿µÄÂѰ×ÅþÁ¬ ¡£ÈôÊÇÁ½¸öÄ¿µÄÂѰ×ÓÉÓÚÓÐÏ໥×÷Óöø¿¿½ü £¬¾ÍʹµÃÓ«¹âÂѰ׵ÄÁ½¸ö·Ö×ÓÆ¬¶ÏÔÚ¿Õ¼äÉÏÏ໥¿¿½ü £¬ÖØÐÂÐγɻîÐÔµÄÓ«¹â»ùÒò¶ø·¢³öÓ«¹â ¡£ÔÚÓ«ÏÊÃ÷΢¾µÏ £¬¾ÍÄÜÖ±½ÓÊӲ쵽Á½Ä¿µÄÂѰ×ÊÇ·ñ¾ßÓÐÏ໥×÷Óà £¬²¢ÇÒÔÚ×î¿¿½ü»îϸ°ûÐÄÀí״̬µÄÌõ¼þÏÂÊӲ쵽ÆäÏ໥×÷Óñ¬·¢µÄʱ¼ä¡¢Î»Öá¢Ç¿Èõ¡¢ËùÐγÉÂѰ׸´ºÏÎïµÄÎȹÌÐÔ £¬ÒÔ¼°Ï¸°ûÐźŷÖ×Ó¶ÔÆäÏ໥×÷ÓõÄÓ°ÏìµÈ £¬ÕâЩÐÅÏ¢¶ÔÑо¿ÂѰ×ÖÊÏ໥×÷ÓÃÓÐÖ÷ÒªÒâÒå ¡£

ØÊºóÉú³¤³öµÄ¶àɫӫ¹â»¥²¹¼¼(multicolor BiFC) £¬²»µ«ÄÜͬʱ¼ì²âµ½¶àÖÖÂѰ×Öʸ´ºÏÌåµÄÐγÉ £¬»¹Äܹ»¶Ô²î±ðÂѰ×Öʼ䱬·¢Ï໥×÷ÓõÄÇ¿Èõ¾ÙÐнÏÁ¿.ÕâÏîÊÖÒÕ²»ÐèÒªÌØÊâµÄ×°±¸ £¬Ï໥×÷ÓõÄÂѰ×Ò²²»ÐèÒªÌØ±ðµÄÀíÂÛÅä±È ¡£Òò´Ë £¬BiFCÊÖÒÕÒѱ»¹ú¼ÊÉÏÖÚ¶àʵÑéÊÒ½ÓÄÉ £¬ÔÚ»îϸ°ûÄÚ֤ʵÂѰ×ÖʵÄÏ໥×÷Óà ¡£±¾ÊµÑéÊÒÀÖ³ÉÓ¦ÓøÃÊÖÒÕÑо¿×ªÂ¼Òò×Óc-Jun¡¢ATF2ºÍc-FosÔÚÔ­´úÉñ¾­ÔªÖеľºÕùÐÔÏ໥×÷Óà ¡£

BiFCÊÖÒÕÒÔϼ¸¸öÌØµãʹÆä¹ØÓÚÑо¿ÂѰ×ÖÊÏ໥×÷ÓþßÓÐÆæÒìµÄÓÅÊÆ£º

1¡¢ÄÜÔÚÏÔ΢¾µÏÂÖ±½ÓÊӲ쵽ÂѰ×Ï໥×÷Óò¢ÇÒ²»ÒÀÀµÓÚÆäËü´Î¼¶Ð§Ó¦ £»2¡¢¸ÃÏ໥×÷ÓÿÉÒÔÔÚ»îϸ°ûÖоÙÐÐÊÓ²ì £¬É¨³ýÁËÓÉÓÚϸ°ûÁѽâ»òÀο¿¿ÉÄÜ´øÀ´µÄ¼ÙÑôÐÔЧ¹û £»3¡¢ÂѰ×ÖÊÔÚ½üËÆÐÄÀíÌõ¼þµÄÇéÐÎϱí´ï £¬±í´ïˮƽ¼°ÌØÕ÷Èç·­ÒëºóÐÞÊμ«´óµØ¿¿½üÓÚÄÚÔ´ÂѰ× £»4¡¢²»ÐèÒªÂѰ×ÖÊÓÐÌØ±ðµÄÀíÂÛÅä±È £¬Äܼì²âµ½²î±ðÑÇȺÂѰ×ÖʼäµÄÏ໥×÷Óà £»5¡¢¶àÉ«BiFCÊÖÒÕ²»µ«ÄÜͬʱ¼ì²âµ½¶àÖÖÂѰ×Öʸ´ºÏÌåµÄÐγÉ £¬»¹Äܹ»¶Ô²î±ðÂѰ×Öʼ䱬·¢Ï໥×÷ÓõÄÇ¿Èõ¾ÙÐнÏÁ¿ £»6¡¢BiFCÊÖÒÕ³ýÁËÓ«¹âµ¹ÖÃÏÔ΢¾µÍâ £¬²»ÒªÇóÌØÊâµÄ×°±¸ ¡£

ʵÑé¼òÆÓ¡¢¿ì½Ý¡¢Ö±¹Û £¬²¢ÊÊÓÃÓÚÔ­ºË¡¢Õæ¾ú¡¢Ö²Îï¡¢¶¯ÎïµÈ¶àÖÖ×éÖ¯¡¢Ï¸°û. ¸ÃÊÖÒÕµÄÍêÉÆÓëÉú³¤Ò»¶¨»áΪÂѰ×ÖÊ×éѧ¡¢ÂѰ×ÖÊÏ໥×÷ÓÃÁ¬ËøÍ¼µÄ½¨Éè´øÀ´¸£Òô. ¿ÉÊÇ £¬¸ÃÊÖÒÕÓë´ó¶à¼ì²âÂѰ×ÖÊÏ໥×÷ÓõÄÊÖÒÕÒ»Ñù £¬Ò²±£´æ×żÙÒõÐԺͼÙÑôÐÔµÄÎÊÌâ £¬ÐèÒªÔÚʵÑéÖÐ×ÐϸÑéÖ¤ ¡£

¶þ¡¢ÊµÑé°ì·¨

1. ½«Ä¿µÄ»ùÒò²åÈëµ½º¬ÓÐNƬ¶Ï»òCƬ¶ÏµÄÔØÌåÖÐ £¬¹¹½¨³ÉÈÚºÏÂѰױí´ïÔØÌå

2. תȾϸ°û £¬Ó«ÏÊÃ÷΢¾µÏÂÊÓ²ìÊÇ·ñÓÐÏ໥×÷Óà ¡£

Èý¡¢Ó¦ÓÃʵÀý

×ðÁú¿­Ê± - ÈËÉú¾ÍÊDz«!

Fig1: Potassium deprivation increases BiFC signals formed by JunVN173 and ATF2VC155. CGNs were transfected with plasmids encoding JunVN173 (JunVN) and ATF2VC155 (ATF2VC) together with ECFP. Jun¦¤L3VN were served as a control. After 16 hr, CGNs were switched to 25K, 5K media for 1h. Photos were taken on a fluorescence microscope at a magnification of 200¡Á. The white arrows indicated the BiFC signals (Venus fluorescence). The transfected cells were lysed for Western blotting by anti-Flag and anti-ATF2 (20F1 CST). CFP were reprobed for normalizing the tranfection efficiency. The percentage of CFP-positive cells exhibiting Venus fluorescence was scored. Data were presented as means ¡À S.E., n=3, Student¡¯s t test, p<0.05.

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿